| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jeffrey Schlom | Q90227155 |
| P2093 | author name string | Claudia Palena | |
| Bruce Huang | |||
| Duane H Hamilton | |||
| Mary T Litzinger | |||
| Romaine I Fernando | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
| Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer | Q24632187 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant | Q24655036 | ||
| Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers | Q24674085 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | Q28131703 | ||
| Correlation of Snail expression with histological grade and lymph node status in breast carcinomas | Q28206944 | ||
| The snail superfamily of zinc-finger transcription factors | Q28216843 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
| The transcriptional repressor Snail promotes mammary tumor recurrence | Q28272823 | ||
| DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells | Q28304564 | ||
| Snail blocks the cell cycle and confers resistance to cell death | Q28572344 | ||
| Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation | Q28589469 | ||
| The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression | Q28595042 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
| Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 | ||
| The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion | Q29616467 | ||
| Molecular requirements for epithelial-mesenchymal transition during tumor progression | Q29618960 | ||
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development | Q30311953 | ||
| The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells | Q33604855 | ||
| Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer | Q33703387 | ||
| Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? | Q33727178 | ||
| Vaccines against human carcinomas: strategies to improve antitumor immune responses | Q33734281 | ||
| Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? | Q33755906 | ||
| Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. | Q33799806 | ||
| p53: a potential target antigen for immunotherapy of cancer | Q33981395 | ||
| Strategies for cancer vaccine development | Q34038338 | ||
| Use of tumour-responsive T cells as cancer treatment | Q34285656 | ||
| Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. | Q34400238 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. | Q34768457 | ||
| Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer | Q35007782 | ||
| The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation | Q35788475 | ||
| Epithelial-mesenchymal transitions: twist in development and metastasis | Q35856121 | ||
| Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion | Q36042084 | ||
| Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients | Q36614440 | ||
| Genetic determinants of cancer metastasis | Q36794312 | ||
| The role of epithelial-mesenchymal transition in cancer pathology | Q36845018 | ||
| Cancer vaccines: moving beyond current paradigms | Q36868126 | ||
| HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses | Q37066149 | ||
| Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target | Q37151287 | ||
| NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression | Q37286365 | ||
| The functioning antigens: beyond just as the immunological targets | Q37483795 | ||
| Epithelial-mesenchymal transition in cancer development and its clinical significance | Q37644546 | ||
| A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. | Q38301815 | ||
| TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells | Q39653885 | ||
| The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition | Q39689085 | ||
| Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells | Q39834964 | ||
| Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation | Q39954485 | ||
| Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype | Q40012189 | ||
| Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. | Q40111238 | ||
| The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. | Q40145050 | ||
| Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. | Q40200816 | ||
| Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines | Q40252973 | ||
| Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma | Q40349219 | ||
| Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition | Q40360895 | ||
| Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target | Q40409031 | ||
| Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition | Q40446051 | ||
| The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors | Q40680001 | ||
| Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways | Q40757186 | ||
| Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses | Q41234424 | ||
| A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer | Q42522113 | ||
| Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. | Q42671796 | ||
| Twist expression in patients with cervical cancer is associated with poor disease outcome | Q43624019 | ||
| Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses | Q44885246 | ||
| Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy | Q46434108 | ||
| Development and characterization of gemcitabine-resistant pancreatic tumor cells. | Q46971449 | ||
| Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. | Q53376881 | ||
| The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. | Q53629087 | ||
| Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. | Q54677737 | ||
| Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients | Q73330168 | ||
| Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments] | Q73368658 | ||
| A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes | Q83139111 | ||
| P433 | issue | 5 | |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 537-545 | |
| P577 | publication date | 2011-03-22 | |
| P1433 | published in | Experimental Biology and Medicine | Q15716535 |
| P1476 | title | Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells | |
| P478 | volume | 236 |
| Q39148033 | A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells |
| Q35741566 | Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody |
| Q37273999 | An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype |
| Q24324198 | Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer |
| Q31153211 | Comparative genomic analysis of primary and synchronous metastatic colorectal cancers |
| Q38067434 | Epithelial-mesenchymal transition in carcinomas of the female genital tract |
| Q33276468 | Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma |
| Q38555670 | Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines. |
| Q33275963 | Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT. |
| Q44392303 | Radiosensitization of brain metastasis by targeting c-MET. |
| Q64246941 | TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma |
| Q39706171 | Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer |
| Q97645866 | The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression |
| Q36985133 | The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies |
| Q39371308 | Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells |
| Q34463393 | mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch |
Search more.